Literature DB >> 17675483

Multiple constraints at the level of TCRalpha rearrangement impact Valpha14i NKT cell development.

Elizabeth Hager1, Abbas Hawwari, Jennifer L Matsuda, Michael S Krangel, Laurent Gapin.   

Abstract

CD1d-restricted NKT cells that express an invariant Valpha14 TCR represent a subset of T cells implicated in the regulation of several immune responses, including autoimmunity, infectious disease, and cancer. Proper rearrangement of Valpha14 with the Jalpha18 gene segment in immature thymocytes is a prerequisite to the production of a TCR that can be subsequently positively selected by CD1d/self-ligand complexes in the thymus and gives rise to the NKT cell population. We show here that Valpha14 to Jalpha rearrangements are temporally regulated during ontogeny providing a molecular explanation to their late appearance in the thymus. Using mice deficient for the transcription factor RORgamma and the germline promoters T early-alpha and Jalpha49, we show that developmental constraints on both Valpha and Jalpha usage impact NKT cell development. Finally, we demonstrate that rearrangements using Valpha14 and Jalpha18 occur normally in the absence of FynT, arguing that the effect of FynT on NKT cell development occurs subsequent to alpha-chain rearrangement. Altogether, this study provides evidence that there is no directed rearrangement of Valpha14 to Jalpha18 segments and supports the instructive selection model for NKT cell selection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17675483     DOI: 10.4049/jimmunol.179.4.2228

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Isolation and Ex Vivo Culture of Vδ1+CD4+γδ T Cells, an Extrathymic αβT-cell Progenitor.

Authors:  Christian Welker; Rupert Handgretinger; Karin Schilbach
Journal:  J Vis Exp       Date:  2015-12-07       Impact factor: 1.355

Review 2.  The ins and outs of type I iNKT cell development.

Authors:  Susannah C Shissler; Tonya J Webb
Journal:  Mol Immunol       Date:  2018-11-28       Impact factor: 4.407

Review 3.  CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system.

Authors:  Jennifer L Matsuda; Thierry Mallevaey; James Scott-Browne; Laurent Gapin
Journal:  Curr Opin Immunol       Date:  2008-05-22       Impact factor: 7.486

4.  Combined deletion of Id2 and Id3 genes reveals multiple roles for E proteins in invariant NKT cell development and expansion.

Authors:  Jia Li; Di Wu; Ning Jiang; Yuan Zhuang
Journal:  J Immunol       Date:  2013-10-11       Impact factor: 5.422

Review 5.  Raising the NKT cell family.

Authors:  Dale I Godfrey; Sanda Stankovic; Alan G Baxter
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

6.  TRIM28 mediates chromatin modifications at the TCRα enhancer and regulates the development of T and natural killer T cells.

Authors:  Xiao-Fei Zhou; Jiayi Yu; Mikyoung Chang; Minying Zhang; Dapeng Zhou; Florence Cammas; Shao-Cong Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

7.  Lower TCR repertoire diversity in Traj18-deficient mice.

Authors:  Romain Bedel; Jennifer L Matsuda; Manfred Brigl; Janice White; John Kappler; Philippa Marrack; Laurent Gapin
Journal:  Nat Immunol       Date:  2012-07-19       Impact factor: 25.606

Review 8.  Orchestration of invariant natural killer T cell development by E and Id proteins.

Authors:  Sumedha Roy; Yuan Zhuang
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

9.  Natural killer T cells constitutively expressing the interleukin-2 receptor α chain early in life are primed to respond to lower antigenic stimulation.

Authors:  Mihoko Ladd; Ashish Sharma; Qing Huang; Adele Y Wang; Lixin Xu; Indira Genowati; Megan K Levings; Pascal M Lavoie
Journal:  Immunology       Date:  2010-10       Impact factor: 7.397

10.  Co-receptor choice by V alpha14i NKT cells is driven by Th-POK expression rather than avoidance of CD8-mediated negative selection.

Authors:  Isaac Engel; Kirsten Hammond; Barbara A Sullivan; Xi He; Ichiro Taniuchi; Dietmar Kappes; Mitchell Kronenberg
Journal:  J Exp Med       Date:  2010-04-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.